Arca
Skip to content
Tools
Tools

Label Changes: Ozempic (semaglutide)

A drug's label (its prescribing information) is revised many times after approval: new warnings, new uses, new doses. DailyMed keeps every version. Pick a drug to see them all and what changed between any two.

Every version of the Ozempic label DailyMed has published, from Novo Nordisk Pharmaceutical Industries, LP, and what changed between any two of them, section by section. Current label on DailyMed.

  • Versions on DailyMed: 19
  • Sections changed, version 19 to 20: 3

What changed from version 19 to version 20

May 21, 2026 to Jun 10, 2026, as published on DailyMed. Added text is underlined in green, removed text struck through in red.
  1. Instructions for Use - 0.25 mg or 0.5 mg doses, 2 mg/3 mL penChanged · 59 words added, 51 removed
  2. Instructions for Use – 1 mg dose, 3 mL penChanged · 59 words added, 51 removed
  3. Instructions for Use – 2 mg dose, 3 mL penChanged · 61 words added, 52 removed

Instructions for Use - 0.25 mg or 0.5 mg doses, 2 mg/3 mL pen

Changed59 words added, 51 removed
1 unchanged line
INSTRUCTIONS FOR USE OZEMPIC® [oh-ZEM-pick] (semaglutide) injection, for subcutaneous use 0.25 mg or 0.5 mg doses (pen delivers doses in 0.25 mg or 0.5 mg increments only)
• Read these instructions carefully before using your OZEMPIC® pen. • Do not use your pen without proper training from your healthcare provider. Make sure that you know how to give yourself an injection with the pen before you start your treatment. • Do not share your OZEMPIC pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them. If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this pen without help. Get help from a person with good eyesight who is trained to use the OZEMPIC pen. • Start by checking your pen to make sure that it contains OZEMPIC, then look at the pictures below to get to know the different parts of your pen and needle. • Your pen is a prefilled, single-patient-use, dial-a-dose pen. It contains 2 mg of semaglutide, and you can select doses of 0.25 mg or 0.5 mg. Each prefilled pen contains 4 doses of 0.25 mg and 2 doses of 0.5 mg or contains 4 doses of 0.5 mg. •YourNovoFine® penPlus is32G made4 tomm bedisposable usedneedles withare NovoFine®included Pluswith oryour NovoFine®OZEMPIC disposablepen. needles• upAlways touse a lengthnew ofneedle 8for mmeach injection. •If you need additional needles, NovoFine® Plus, 32GNovoFine® 4or mmother compatible disposable needles arewith includeda withlength yourup OZEMPICto pen.8 •mm Alwayscan usebe aused. newFor needle forcompatibility eachinformation, injectiontalk to your healthcare professional. Supplies you will need to give your OZEMPIC injection: •OZEMPIC pen •a new NovoFine Plus, NovoFine, or NovoFineother compatible needle •1 alcohol swab •1 gauze pad or cotton ball •1 sharps disposal container for throwing away used OZEMPIC pens and needles. See “Disposing of used OZEMPIC pens and needles” at the end of these instructions. |
Step 1. Prepare your pen with a new needle
32 unchanged lines
Caring for your pen
• Do not drop your pen or knock it against hard surfaces. If you drop it or suspect a problem, attach a new needle and check the OZEMPIC flow before you inject. • Do not try to repair your pen or pull it apart. • Do not expose your pen to dust, dirt or liquid. • Do not wash, soak, or lubricate your pen. If necessary, clean it with mild detergent on a moistened cloth. How should I store my OZEMPIC pen? •Store your new, unused OZEMPIC pens in the refrigerator between 36°F to 46°F (2°C to 8°C). • Store your pen in use for 56 days at room temperature between 59ºF to 86ºF (15ºC to 30ºC) or in a refrigerator between 36°F to 46°F (2°C to 8°C). •The OZEMPIC pen you are using should be disposed of (thrown away) after 56 days, even if it still has OZEMPIC left in it. Write the disposal date on your calendar. • Do not freeze OZEMPIC. Do not use OZEMPIC if it has been frozen. •Unused OZEMPIC pens may be used until the expiration date (“EXP”) printed on the label, if kept in the refrigerator. •When stored in the refrigerator, do not store OZEMPIC pens directly next to the cooling element. •Keep OZEMPIC away from heat and out of the light. • Keep the pen cap on when not in use. • Keep OZEMPIC and all medicines out of the reach of children. For more information go to www.OZEMPIC.com ManufacturedMarketed by: Novo Nordisk, A/SInc. DK-2880Plainsboro, BagsvaerdNJ Denmark08536 For information about OZEMPIC contact: Novo Nordisk Inc. 800 Scudders Mill Road Plainsboro, NJ 08536 1-888-693-6742 Version: 2 OZEMPIC® and NovoFine® are registered trademarks of Novo Nordisk A/S. PATENTPatent Information: https://www.novonordisk-us.com/products/product-patents.html © 20232026 Novo Nordisk This Instructions for Use has been approved by the U.S. Food and Drug Administration. Revised: September 2023June/2026

Instructions for Use – 1 mg dose, 3 mL pen

Changed59 words added, 51 removed
1 unchanged line
INSTRUCTIONS FOR USE OZEMPIC® [oh-ZEM-pick] (semaglutide) injection, for subcutaneous use 1 mg dose (pen delivers doses in 1 mg increments only)
• Read these instructions carefully before using your OZEMPIC® pen. • Do not use your pen without proper training from your healthcare provider. Make sure that you know how to give yourself an injection with the pen before you start your treatment. • Do not share your OZEMPIC pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them. If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this pen without help. Get help from a person with good eyesight who is trained to use the OZEMPIC pen. • Start by checking your pen to make sure that it contains OZEMPIC, then look at the pictures below to get to know the different parts of your pen and needle. • Your pen is a prefilled, single-patient-use, dial-a-dose pen. It contains 4 mg of semaglutide, and you can only select doses of 1 mg. Each prefilled pen contains 4 doses of 1 mg. •YourNovoFine® penPlus is32G made4 tomm bedisposable usedneedles withare NovoFine®included Pluswith oryour NovoFine®OZEMPIC disposablepen. needles• upAlways touse a lengthnew ofneedle 8for mmeach injection. •If you need additional needles, NovoFine® Plus, 32GNovoFine® 4or mmother compatible disposable needles arewith includeda withlength yourup OZEMPICto pen.8 •mm Alwayscan usebe aused. newFor needle forcompatibility eachinformation, injectiontalk to your healthcare professional. Supplies you will need to give your OZEMPIC injection: •OZEMPIC pen 1 mg dose •a new NovoFine Plus, NovoFine, or NovoFineother compatible needle •1 alcohol swab •1 gauze pad or cotton ball •1 sharps disposal container for throwing away used OZEMPIC pens and needles. See “Disposing of used OZEMPIC pens and needles” at the end of these instructions. |
Step 1. Prepare your pen with a new needle
32 unchanged lines
Caring for your pen
• Do not drop your pen or knock it against hard surfaces. If you drop it or suspect a problem, attach a new needle and check the OZEMPIC flow before you inject. • Do not try to repair your pen or pull it apart. • Do not expose your pen to dust, dirt or liquid. • Do not wash, soak, or lubricate your pen. If necessary, clean it with mild detergent on a moistened cloth. How should I store my OZEMPIC pen? •Store your new, unused OZEMPIC pens in the refrigerator between 36°F to 46°F (2°C to 8°C). • Store your pen in use for 56 days at room temperature between 59ºF to 86ºF (15ºC to 30ºC) or in a refrigerator between 36°F to 46°F (2°C to 8°C). •The OZEMPIC pen you are using should be disposed of (thrown away) after 56 days, even if it still has OZEMPIC left in it. Write the disposal date on your calendar. • Do not freeze OZEMPIC. Do not use OZEMPIC if it has been frozen. •Unused OZEMPIC pens may be used until the expiration date (“EXP”) printed on the label, if kept in the refrigerator. •When stored in the refrigerator, do not store OZEMPIC pens directly next to the cooling element. •Keep OZEMPIC away from heat and out of the light. • Keep the pen cap on when not in use. • Keep OZEMPIC and all medicines out of the reach of children. For more information go to www.OZEMPIC.com ManufacturedMarketed by: Novo Nordisk, A/SInc. DK-2880Plainsboro, BagsvaerdNJ Denmark08536 For information about OZEMPIC contact: Novo Nordisk Inc. 800 Scudders Mill Road Plainsboro, NJ 08536 1-888-693-6742 Version: 4 OZEMPIC® and NovoFine® are registered trademarks of Novo Nordisk A/S. PATENTPatent Information: https://www.novonordisk-us.com/products/product-patents.html © 20232026 Novo Nordisk This Instructions for Use has been approved by the U.S. Food and Drug Administration. Revised: September 2023June/2026

Instructions for Use – 2 mg dose, 3 mL pen

Changed61 words added, 52 removed
1 unchanged line
INSTRUCTIONS FOR USE OZEMPIC® [oh-ZEM-pick] (semaglutide) injection, for subcutaneous use 2 mg dose (pen delivers doses in 2 mg increments only)
• Read these instructions carefully before using your OZEMPIC® pen. • Do not use your pen without proper training from your healthcare provider. Make sure that you know how to give yourself an injection with the pen before you start your treatment. • Do not share your OZEMPIC pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them. If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this pen without help. Get help from a person with good eyesight who is trained to use the OZEMPIC pen. • Start by checking your pen to make sure that it contains OZEMPIC, then look at the pictures below to get to know the different parts of your pen and needle. • Your pen is a prefilled, single-patient-use, dial-a-dose pen. It contains 8 mg of semaglutide, and you can only select doses of 2 mg. Each prefilled pen contains 4 doses of 2 mg. •YourNovoFine® penPlus is32G made4 tomm bedisposable usedneedles withare NovoFine®included Pluswith oryour NovoFine®OZEMPIC disposablepen. needles• upAlways touse a lengthnew ofneedle 8for mmeach injection. •If you need additional needles, NovoFine® Plus, 32GNovoFine® 4or mmother compatible disposable needles arewith includeda withlength yourup OZEMPICto pen.8 •mm Alwayscan usebe aused. newFor needle forcompatibility eachinformation, injectiontalk to your healthcare professional. Supplies you will need to give your OZEMPIC injection: •OZEMPIC pen 2 mg dose •a new NovoFine Plus, NovoFine, or NovoFineother compatible needle •1 alcohol swab •1 gauze pad or cotton ball •1 sharps disposal container for throwing away used OZEMPIC pens and needles. See “Disposing of used OZEMPIC pens and needles” at the end of these instructions. |
Step 1. Prepare your pen with a new needle
34 unchanged lines
For more information go to www.OZEMPIC.com
Manufactured by:
Marketed by:
Novo Nordisk, A/SInc.
DK-2880 Bagsvaerd
Denmark
Plainsboro, NJ
08536
For information about OZEMPIC contact:
3 unchanged lines
1-888-693-6742
Version: 2
OZEMPIC® and NovoFine® are registered trademarks of Novo Nordisk A/S.
PATENTPatent Information: https://novonordisk-us.com/products/product-patents.html
© 20232026 Novo Nordisk
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Revised: September 2023
Revised: June/2026

Unchanged: Boxed warning, Indications and usage, Dosage and administration, Dosage forms and strengths, Contraindications, Warnings and precautions, Adverse reactions, Drug interactions, Use in specific populations, Overdosage, Description, Clinical pharmacology, Nonclinical toxicology, Clinical studies, How supplied, Patient counseling information, Medication guide, Instructions for Use – 0.25 mg, 0.5 mg, 1 mg single-dose prefilled syringe, PRINCIPAL DISPLAY PANEL – 0.25 mg or 0.5 mg doses, 2 mg/3mL – Pen, PRINCIPAL DISPLAY PANEL – 1 mg dose, 4 mg/3 mL – Pen, PRINCIPAL DISPLAY PANEL – 2 mg dose, 8mg/3 mL – Pen, PACKAGE/LABEL PRINCIPAL DISPLAY PANEL – 0.25 mg and 0/5 mg, 1.5 mL – Pen, PACKAGE/LABEL PRINCIPAL DISPLAY PANEL – 1 mg, 1.5 mL – Pen, Package/Label Display Panel – 0.25 mg/0.5 mL – Syringe, Package/Label Display Panel – 0.5 mg/0.5 mL – Syringe, Package/Label Display Panel – 1 mg/0.5 mL – Syringe.

Every version

19 versions of set adec4fd2-6858-4c99-91d4-531f5f2a2d79, newest first.

Read an SPL file

Open an SPL label file

Drop a Structured Product Labeling .xml file, or the .zip DailyMed downloads, to read it as a label. It is read in this browser tab and not uploaded.

Read in this browser tab; nothing is uploaded.

Versions and label text from DailyMed's SPL web services; a version's text is read from its SPL file, so it matches what DailyMed shows. Recent safety-related changes from FDA's Safety-related Labeling Changes database, which covers NDAs and CDER biologics, not generics. Lists refresh daily. DailyMed, National Library of Medicine

About label change history

How to read a comparison

Sections that changed come first, in the order a reviewer reads a label: boxed warning, recent major changes, indications, dosage, contraindications, warnings and precautions, adverse reactions, then the rest. Each shows the changed lines with one unchanged line either side; longer unchanged stretches are folded into a count. Table rows read left to right with cells separated by a bar.

The comparison covers the label text. Images, product data (NDC codes, ingredients, packaging) and formatting are not compared.

Which label is shown

A drug can have several labels: one per brand-name application (Ozempic, Wegovy and Rybelsus are three), and copies from repackagers. For each NDA or BLA the page takes the DailyMed set with the most versions, which is the application holder's. Generic labels are left out; they follow the brand's label.

Frequently asked questions

Where do the versions come from?
DailyMed, the National Library of Medicine's library of labels in Structured Product Labeling (SPL) format. Each time a company submits a revised label, DailyMed publishes it as a new version of the same set and keeps the old ones.
Is a new version a new FDA approval?
Not always. Companies also submit new versions for changes that need no FDA approval first, such as a new address, a new package size or a corrected typo. Safety changes FDA approved are listed in its Safety-related Labeling Changes database, linked below.
Why does the published date differ from the label's revised date?
The published date is when DailyMed posted the version. The label's own revised date, at the end of the highlights, is when the company revised the text, usually a few days to weeks earlier.
How is the comparison made?
Each section is matched by its standard LOINC code, then split into headings, paragraphs, list items and table rows. Lines are aligned with a longest-common-subsequence diff; a removed and an added line that share at least half their words are shown as one edited line with the changed words marked. Curly quotes, dash styles and spacing are ignored.
Is my SPL file uploaded?
No. A file you drop on this page is read in your browser tab and never sent to Arca.
Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.